Etanercept treatment in juvenile idiopathic arthritis: The Polish registry

Medical Science Monitor

Volumn 17, Issue 12, 2011, Pages

  Zuber, Zbigniew ^a   Rutkowska Sak, Lidia ^b   Postepski, Jacek ^c   Dobrzyniecka, Bogna ^d   Opoka Winiarska, Violetta ^c   Kobusińska, Katarzyna ^e   Gietka, Piotr ^c   Osińska, Violetta ^e   Turowska Heydel, Dorota ^a   Szczygielska, Izabela ^b   Kołodziejczyk, Beata ^b   Światek Baczkowska, Anna ^f   Gazda, Agnieszka ^b   Wiland, Piotr ^g   Tłustochowicz, Witold ^h   Tuszkiewicz Misztal, Ewa ⁱ  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d A Falkiewicz's Specialist Hospital   (Poland)

^e Brudzinski's Voyvod Children's Hospital   (Poland)

^f John Paul II's Paediatric Centre   (Poland)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h MILITARY INSTITUTE OF MEDICINE   (Poland)

ⁱ Polish Society for Rheumatology   (Poland)

Author keywords

Efficacy; Etanercept; Juvenile idiopathic arthritis; Registry; Safety

Indexed keywords

ETANERCEPT;

ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCARIASIS; ASTHMA; BRONCHITIS; CHICKENPOX; CHILD; COMMON COLD; CYTOMEGALOVIRUS INFECTION; DERMATITIS; DIARRHEA; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOOT DISEASE; FRAGILITY FRACTURE; GASTROENTERITIS; GRAM NEGATIVE SEPSIS; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; INFLAMMATION; INFLUENZA; JUVENILE RHEUMATOID ARTHRITIS; LARYNGITIS; LEUKOPENIA; LOWER RESPIRATORY TRACT INFECTION; LYMPHANGITIS; MACROPHAGE ACTIVATION SYNDROME; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENINGITIS; ORBIT EDEMA; OTITIS MEDIA; PARAINFLUENZA VIRUS INFECTION; PARONYCHIA; PHARYNGITIS; POLAND; PRESCHOOL CHILD; RHINITIS; SCABIES; SCARLET FEVER; SCHOOL CHILD; SIDE EFFECT; SINUSITIS; SKIN DISEASE; STOMATITIS; TONSILLITIS; TOOTH ABSCESS; TREATMENT OUTCOME; TUBERCULOSIS; URINARY TRACT INFECTION; URTICARIA; UVEITIS; YERSINIA INFECTION;

EID: 82755197281     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882109     Document Type: Article

References (15)

1. Rutkowska-Sak L, Tuszkiewicz-Misztal E, Brózik H et al: The Paediatric Rheumatology Expert Panel of the National Consultant for Rheumatology standpoint for the biologic therapy of juvenile idiopathic arthritis. Reumatologia, 2009; 47: 111-15
2. Wolny-Niedzielska A: Choroby układu ruchu u dzieci kierowanych do Poradni Reumatologicznej w Kielcach w latach 1999-2003. Reumatologia, 2005; 43: 265-73 [in Polish]
3. Zygmunt A, Biernacka-Zielinska M, Brózik H et al: Choroby reumatyczne w populacji dzieci i młodzieży z regionu łódzkiego. Ped Pol, 2005; 80: 995-1001 [in Polish]
4. Horneff G, Schmeling H, Biedermann T et al: The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis, 2004; 63: 1638-44
5. Horneff G, Ebert A, Fitter S et al: Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis. Rheumatology, 2009; 48: 916-19
6. Horneff G, De Bock F, Foeldvari I et al: Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis, 2009; 68: 635-41
7. Prince FH, Twilt M, Ten Cate R et al: Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis, 2009; 68: 635-41
8. rd Workshop of European Biologics Registries Ann Rheum Dis 2005; 64: 644. Available from: URL: http://ard.bmj.com/content/suppl/2005/03/21/64.4.644.DC1/644644summary2.pdf
9. Petty RE, Southwood TR, Baum J et al: Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol, 1998; 25: 1991-94
10. Giannini EH, Ruperto N, Ravelli A et al: Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum, 1997; 40: 1202-9
11. Lovell DJ, Giannini EH, Reiff A et al: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med, 2000; 342: 763-69
12. Lovell DJ, Reiff A, Jones OY et al: Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum, 2006; 54: 1987-94
13. Lovell DJ, Reiff A, Ilowite NT et al: Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum, 2008; 58: 1496-504
14. Lahdenne P, Vahasalo P, Honkanen V: Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis, 2003; 62: 245-47
15. Quartier P, Taupin P, Bourdeaut F et al: Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum, 2003; 48: 1093-101